Page last updated: 2024-12-10

12-deoxyphorbolphenylacetate-20-acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

**12-deoxyphorbolphenylacetate-20-acetate (DPP)** is a potent tumor promoter, belonging to the class of **phorbol esters**.

**Structure and Mechanism:**

DPP is a highly lipophilic molecule with a complex structure. Its main functional group is the **phorbol moiety**, which binds to **protein kinase C (PKC)**, a family of enzymes that play a crucial role in cell signaling pathways.

Upon binding to PKC, DPP activates the enzyme, leading to a cascade of downstream signaling events. This activation can induce various cellular responses, including:

* **Cell proliferation:** Stimulating cell growth and division.
* **Differentiation:** Promoting the development of cells into specialized types.
* **Apoptosis:** Triggering programmed cell death.
* **Inflammation:** Contributing to inflammatory processes.
* **Tumor promotion:** Inducing the development of cancer.

**Importance in Research:**

DPP is a valuable tool in cancer research due to its ability to:

* **Investigate PKC signaling pathways:** As a potent activator of PKC, DPP allows researchers to study the role of this enzyme in various cellular processes.
* **Model tumor promotion:** DPP mimics the effects of tumor promoters, providing insights into the mechanisms underlying cancer development.
* **Develop new anti-cancer therapies:** Understanding DPP's mode of action can aid in the development of drugs targeting PKC or other signaling pathways involved in tumor promotion.
* **Screen for anti-tumor agents:** DPP can be used as a tool to identify potential anti-cancer drugs that inhibit its activity or downstream signaling.

**Safety Considerations:**

DPP is a highly toxic compound and should only be handled by trained professionals in a laboratory setting. Its potent tumor-promoting properties require careful handling and appropriate safety measures.

**Other Important Points:**

* DPP is closely related to **phorbol 12-myristate 13-acetate (PMA)**, another potent tumor promoter.
* DPP's activity is dependent on its concentration and the specific cell type.
* DPP has been used in various research areas, including cancer biology, immunology, and pharmacology.

**Conclusion:**

12-deoxyphorbolphenylacetate-20-acetate is a powerful research tool with significant implications for understanding cancer biology and developing new therapeutic approaches. Its potent tumor-promoting activity, combined with its ability to activate PKC signaling, makes it an invaluable reagent for studying cellular processes and potential drug targets. However, its toxicity and potential carcinogenic effects require careful handling and responsible use in research settings.

Cross-References

ID SourceID
PubMed CID3034821
CHEMBL ID1395147
SCHEMBL ID15423126
MeSH IDM0094576

Synonyms (19)

Synonym
12-deoxyphorbolphenylacetate-20-acetate
benzeneacetic acid ,(1ar,1bs,4ar,7as,7br,8r,9as)-3-((acetyloxy)methyl)-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-4a,7b-dihydroxy-1,1,6,8-tetramethyl-5-oxo-9ah-cyclopropa(3,4)benz(1,2-e)azulen-9a-yl ester
5h-cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-4a-beta,7b-alpha,9a-alpha-trihydroxy-3-(hydroxymethyl)-1,1,6,8-alpha-tetramethyl-, 3-acetate 9a-phenylacetate
12-deoxyphorbol-13-phenylacetate-20-acetate
NCGC00163537-01
12-deoxyphorbol 13-phenylacetate 20-acetate
54662-30-5
CHEMBL1395147
doppa
CCG-208193
SCHEMBL15423126
(acetoxymethyl-dihydroxy-tetramethyl-oxo-[?]yl) 2-phenylacetate
dppa, >=98% (hplc)
SR-05000002352-2
sr-05000002352
MEDVHSNRBPAIPU-XMOZQXTISA-N
[(1r,2s,6r,10s,11r,13s,15r)-8-(acetyloxymethyl)-1,6-dihydroxy-4,12,12,15-tetramethyl-5-oxo-13-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] 2-phenylacetate
3-[(acetyloxy)methyl]-4a,7b-dihydroxy-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9ah-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl phenylacetate
DTXSID20969948
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATAD5 protein, partialHomo sapiens (human)Potency0.86890.004110.890331.5287AID624252; AID686934; AID720565
glucocerebrosidaseHomo sapiens (human)Potency0.70790.01268.156944.6684AID2101
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency19.95260.00798.23321,122.0200AID2546
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (21.43)18.7374
1990's5 (35.71)18.2507
2000's4 (28.57)29.6817
2010's2 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.72 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.43 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]